Abstract
The Immunogenicity, Safety and Efficacy of N8-GP in Previously Untreated Patients (PUPs) with Severe Hemophilia A: pathfinder6 End-of-Trial Results
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have